Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy
No Thumbnail Available
Issue Date
2016
Our author(s)
Tahir, S.
Department
Keywords
Language
English
Publisher
Massachussetts Medical Society
ISSN
0028-4793
1533-4406
1533-4406
eISSN
ISBN
Type
article
Citation
Eggermont, A. M. M., Chiarion-Sileni, V., Grob, J. J., Dummer, R., Wolchok, J. D., Schmidt, H., Hamid, O., Robert, C., Ascierto, P. A., Richards, J. M., Lebbe, C., Ferraresi, V., Smylie, M., Weber, J. S., Maio, M., Bastholt, L., Mortier, L., Thomas, L., Tahir, S., Hauschild, A., Hassel, J. C., Hodi, F. S., Taitt, C., De Pril, V., De Schaetzen, G., Suciu, S. & Testori, A. 2016. Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy. New England Journal of Medicine, 375, (19) 1845-1855.